Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

被引:157
作者
Salio, M [1 ]
Cella, M
Vermi, W
Facchetti, F
Palmowski, MJ
Smith, CL
Shepherd, D
Colonna, M
Cerundolo, V
机构
[1] John Radcliffe Hosp, Weatherall Inst Mol Med, Tumor Immunol Unit, Oxford OX3 9DS, England
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
[3] Univ Brescia, Ist Anat Patol, Brescia, Italy
关键词
plasmacytoid dendritic cell; priming; Melan-A; tetramer; tumor immunity;
D O I
10.1002/eji.200323676
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmacytoid dendritic cells (PDC) are a small population of leukocytes specialized in the production of type I IFN. It has been shown that PDC have a potent T cell stimulatory capacity in allogeneic mixed lymphocyte reaction, However, their role in initiating primary immune responses remains elusive. We report that blood PDC efficiently prime naive CD8(+) lymphocytes specific for the melan-A(26-35) epitope to become IFN-gamma producing cells in vitro. In addition, we found that CD40L-stimulated PDC induce expression on primed melan-A-specific T cells of cutaneous lymphocyte antigen and L-selectin (CD62L), homing receptors that allow the migration of effector cells to the inflamed skin. Finally, we show that PDC can be found in the peri-tumoral area of most primary cutaneous melanomas in vivo and that type I IFN-containing supernatants derived from PDC increase melanoma cell surface expression of CD95 and MHC class I and class II molecules in vitro. Our results suggest a new immunomodulatory role for tissue infiltrating PDC, which may prime tumor-specific T cell responses and affect tumor growth via soluble factors.
引用
收藏
页码:1052 / 1062
页数:11
相关论文
共 52 条
[1]   Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].
Albert, ML ;
Pearce, SFA ;
Francisco, LM ;
Sauter, B ;
Roy, P ;
Silverstein, RL ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368
[2]   The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues [J].
Allavena, P ;
Sica, A ;
Vecchi, A ;
Locati, M ;
Sozzani, S ;
Mantovani, A .
IMMUNOLOGICAL REVIEWS, 2000, 177 :141-149
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]  
Belardelli F, 1998, CANCER RES, V58, P5795
[5]   Cytokines as a link between innate and adaptive antitumor immunity [J].
Belardelli, F ;
Ferrantini, M .
TRENDS IN IMMUNOLOGY, 2002, 23 (04) :201-208
[6]   In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas [J].
Bell, D ;
Chomarat, P ;
Broyles, D ;
Netto, G ;
Harb, GM ;
Lebecque, S ;
Valladeau, J ;
Davoust, J ;
Palucka, KA ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1417-1425
[7]   THE CUTANEOUS LYMPHOCYTE ANTIGEN IS A SKIN LYMPHOCYTE HOMING RECEPTOR FOR THE VASCULAR LECTIN ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULE-1 [J].
BERG, EL ;
YOSHINO, T ;
ROTT, LS ;
ROBINSON, MK ;
WARNOCK, RA ;
KISHIMOTO, TK ;
PICKER, LJ ;
BUTCHER, EC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1461-1466
[8]   Frequent downregulation of Fas (CD95) expression and function in melanoma [J].
Bullani, RR ;
Wehrli, P ;
Viard-Leveugle, I ;
Rimoldi, D ;
Cerottini, JC ;
Saurat, JH ;
Tschopp, J ;
French, LE .
MELANOMA RESEARCH, 2002, 12 (03) :263-270
[9]   Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent THI polarization [J].
Cella, M ;
Facchetti, F ;
Lanzavecchia, A ;
Colonna, M .
NATURE IMMUNOLOGY, 2000, 1 (04) :305-310
[10]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752